Healthcare Agency Refreshing Big Medical Survey Data
Published Date: 12/30/2025
Notice
Summary
The Agency for Healthcare Research and Quality wants to update its big health survey that tracks how Americans use and pay for medical care. This affects families, doctors, and employers nationwide and helps shape healthcare policies. They’re asking for your comments by March 2, 2026, to keep this important data collection running smoothly without extra costs.
Analyzed Economic Effects
2 provisions identified: 0 benefits, 1 costs, 1 mixed.
Survey Time and Cost Burden
The revised Medical Expenditure Panel Survey (MEPS) will require a total estimated 50,264 respondent burden hours per year and an estimated annual respondent cost burden of $3,108,705. That total includes 42,219 hours and $2,757,745 for the household component (MEPS-HC) and 8,045 hours and $350,960 for the medical provider component (MEPS-MPC).
Changes to Preventive Care Questions
The Preventive Care Self-Administered Questionnaire (PSAQ) will be revised and fielded in the Fall of 2026: four counseling/treatment questions, one birth control question, two aspirin questions, and two gender questions will be removed; the PSAQ will revert to the 2022 question about respondent sex; two exercise items will be replaced by five new exercise and strength training items; and new questions will be added on sleep medication, trouble getting to sleep, screen time, wearable device use, self-assessed diet quality, fruit and vegetable consumption, meals eaten away from home, former smoking, and weight loss attempts. Additionally, the Burdens and Economic Impacts of Medical Care Self-Administered Questionnaire (ESAQ) and the Diabetes Care Supplement (DCS) will be discontinued.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-17164, Agency Information Collection Activities: Proposed Collection; Comment Request
This notice announces the intention of the Agency for Healthcare Research and Quality (AHRQ) to request that the Office of Management and Budget (OMB) approve the reinstatement with change of the previously approved information collection project "AHRQ Research Reporting System (ARRS)" OMB No 0935-0122. This information collection was previously published in the Federal Register on June 17, 2026, and allowed 60 days for public comment. AHRQ did not receive any comments. The purpose of this notice is to allow an additional 30 days for public comment. The package expired on July 31, 2027.
2026-15324, Agency Information Collection Activities: Proposed Collection; Comment Request
This notice announces the intention of the Agency for Healthcare Research and Quality (AHRQ) to request that the Office of Management and Budget (OMB) approve the extension with change of the currently approved information collection "AHRQ Consumer Assessment of Healthcare Providers and Systems (CAHPS) Database for Health Plans" (OMB Control number 0935-0165, last approved on December 31, 2023).
2026-14313, Patient Safety Organizations: Expired Listing for the Informed Patient Safety Organization (IPSO)
The Informed Patient Safety Organization (IPSO) has been officially removed from the list of recognized Patient Safety Organizations because its listing expired on July 6, 2026. This change affects healthcare providers who rely on IPSO for confidential patient safety reporting. No money changes hands, but providers should check the updated list to know which organizations are currently active.
2026-13604, Patient Safety Organizations: Voluntary Relinquishment for the Cassatt Patient Safety Organization
The Cassatt Patient Safety Organization has decided to give up its official status as a Patient Safety Organization (PSO), and the government has accepted this change. This means Cassatt will no longer be listed as a PSO starting June 8, 2026. Healthcare providers who worked with Cassatt should note this change, but there’s no direct cost impact involved.
2026-12174, Agency Information Collection Activities: Proposed Collection; Comment Request
The Agency for Healthcare Research and Quality (AHRQ) wants to update and extend its research reporting system, making it easier and less time-consuming for grant and contract recipients to share progress. This change affects researchers funded by AHRQ through grants, contracts, and competitions, and aims to reduce paperwork while expanding who uses the system. Comments on these changes are open until August 17, 2026, so now’s the time to speak up!
2026-08173, Patient Safety Organizations: Voluntary Relinquishment for Collaborative Healthcare Patient Safety Organization
The Collaborative Healthcare Patient Safety Organization (PSO) has chosen to give up its official PSO status, and the government made it official on March 23, 2026. This change affects healthcare providers who worked with this PSO for patient safety reporting and means they’ll need to find new ways to share safety info. No new costs or deadlines for providers, but the PSO list is updated weekly online for easy checking.
Previous / Next Documents
Previous: 2025-23962, The RBB Fund Trust and Twin Oak ETF Company
The RBB Fund Trust and Twin Oak ETF Company want to change how they work with their subadvisers by skipping shareholder approval for some agreements and sharing less info about fees. This means faster updates and less paperwork for them, but shareholders should watch for any hearing requests by January 16, 2026. No big money changes are announced, just smoother management moves.
Next: 2025-23965, Steel Concrete Reinforcing Bar From Algeria, Bulgaria, Egypt, and Vietnam; Scheduling of the Final Phase of Countervailing Duty and Antidumping Duty Investigations
The U.S. is checking if steel concrete reinforcing bars (rebar) from Algeria, Bulgaria, Egypt, and Vietnam are being sold unfairly cheap or getting special government help. This could affect import rules and possibly add extra taxes to protect U.S. businesses. The final decision is moving forward after a preliminary look, with important updates expected soon.